Internal Medicine, Hematology & Oncology · New York, NY
NPI
1619049053
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave, Howard 713
New York, NY, 10065
Phone (212) 639-4812
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
275 services
Medicare patients, 2024
196
Average age 73
Drug cost, 2024
$271K
321 prescriptions
Company payments, 2023
$18.24
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rekha Parameswaran was code 99214 (office e&m - established), 151 times for 111 patients. In total Rekha Parameswaran billed 275 services in 14 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 151 | 111 | $92.61 | $14K |
| 99205 Office E&M - New | Office | 38 | 38 | $183.76 | $6,983 |
| 99213 Office E&M - Established | Office | 19 | 19 | $67.40 | $1,281 |
| 99222 Hospital E&M - Initial | Facility | 14 | 14 | $115.12 | $1,612 |
| 99223 Hospital E&M - Initial | Facility | 12 | 12 | $151.69 | $1,820 |
By year: 2022 $34K for 310 services; 2023 $38K for 369 services; 2024 $30K for 275 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rekha Parameswaran prescribed most often to Medicare patients was Eliquis (Apixaban), with 127 prescriptions and refills. In total Rekha Parameswaran wrote 321 Medicare prescriptions that cost $271K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 127 | 213 | 40 | $123K |
| Enoxaparin Sodium Generic | 91 | 138 | 33 | $25K |
| Xarelto Rivaroxaban | 82 | 138 | 29 | $75K |
Brand drugs: 216 claims; generic drugs: 105 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Rekha Parameswaran $18.24 ($18.24 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $18.24.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $18.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.